Discontinued — last reported Q3 '25
Equity
Cumulative Gross Losses and Impairments
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2017
Last reportedQ3 2025
How to read this metric
An increase signals deteriorating value in the investment portfolio, potentially leading to future earnings charges.
Detailed definition
This represents the total unrealized losses and impairment charges on investments that have not yet been reflected in ne...
Peer comparison
Varies significantly based on the size and nature of a company's investment portfolio.
Metric ID:
cumulative_gross_losses_and_impairmentsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Range$0.00 – $0.00
Cumulative Gross Losses and Impairments at Other Companies
Frequently Asked Questions
- What is Biogen's cumulative gross losses and impairments?
- Biogen (BIIB) reported cumulative gross losses and impairments of $0.00 in Q1 2026.
- What does cumulative gross losses and impairments mean?
- The total amount of unrealized losses and impairments on investments.